tiprankstipranks
Advertisement
Advertisement

BLRX Stock Latest News

BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
Company AnnouncementsBioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
12m ago
6K
BLRX
BioLineRx initiates Phase 1/2a study of GLIX1
PremiumThe Fly
BioLineRx initiates Phase 1/2a study of GLIX1
33m ago
BLRX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
3d ago
LAR
MBX
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
3d ago
AIR
CCL
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
PremiumCompany Announcements
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
3d ago
6K
BLRX
BioLineRx provides corporate update
PremiumThe FlyBioLineRx provides corporate update
3d ago
BLRX
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
16d ago
BLRX
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
Premium
Company Announcements
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
1M ago
6K
BLRX
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
PremiumCompany Announcements
BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges
4M ago
BLRX
BioLineRx Reports Q3 2025 Results and Strategic Expansion
PremiumCompany Announcements
BioLineRx Reports Q3 2025 Results and Strategic Expansion
4M ago
BLRX
BioLineRx Announces Q3 2025 Financial Results and New Joint Venture
PremiumCompany Announcements
BioLineRx Announces Q3 2025 Financial Results and New Joint Venture
4M ago
6K
BLRX
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
PremiumThe Fly
Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results
4M ago
NVO
WRD
Options Volatility and Implied Earnings Moves Today, November 24, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, November 24, 2025
4M ago
A
LX
BioLineRx reports Q3 EPS 0c vs 0c last year
Premium
The Fly
BioLineRx reports Q3 EPS 0c vs 0c last year
4M ago
BLRX
Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, November 24 – November 26, 2025
4M ago
A
DE
BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
BLRX
BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1
PremiumCompany Announcements
BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1
4M ago
6K
BLRX
BioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma
PremiumCompany Announcements
BioLineRx and Hemispherian Launch Joint Venture to Develop GLIX1 for Glioblastoma
6M ago
6K
BLRX
BioLineRx, Hemispherian AS establish joint venture to develop GLIX1
PremiumThe Fly
BioLineRx, Hemispherian AS establish joint venture to develop GLIX1
6M ago
BLRX
BioLineRx ADR Earnings Call: Optimism Amid Challenges
PremiumCompany AnnouncementsBioLineRx ADR Earnings Call: Optimism Amid Challenges
7M ago
BLRX
BioLineRx: Strategic Pipeline Expansion and Strong Financial Health Justify Buy Rating
Premium
Ratings
BioLineRx: Strategic Pipeline Expansion and Strong Financial Health Justify Buy Rating
7M ago
BLRX
BioLineRx Ltd. Reports Q2 2025 Financial Results
Premium
Company Announcements
BioLineRx Ltd. Reports Q2 2025 Financial Results
7M ago
BLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >